Value Investing Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Paul Senior who wrote (33599)	2/21/2009 1:47:12 PM
From: Madharry	of 78744

Your comment strikes a cord of memory in me. I remember how my wife heard some wonderful speaker talk about research work that he did involving non-drug psychiatric therapy. My wife asked him where she could read about it and he intimated that it would be very difficult because the whole system is geared toward psychiatric medications for patients rather than alternatives. That is where the funding is, hence that is where the research dollars are spent, those are the types of researchers and professors hired by universities, those are the editors hired to write the textbooks and edit the professional journals. Its just one vicious circle all geared toward perpetuating psychiatric medications as the treatment of choice depite that toxicity of drugs, the side effects and the interactive issues with other medications and foods. Then other therapies are poo-pooed in that they have not passed scientific testing yet there are no dollars for it. There is also local influence pedalling. Our local health system managed to get some law passed in Mass. so that they could remain a virtual monopoly in this area. A competitive radiaology group had to move out of state to work.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next